Assessment of Endocan Serum Levels in Patients With Behcet Disease
NCT ID: NCT03853135
Last Updated: 2020-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
84 participants
OBSERVATIONAL
2019-02-27
2019-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calprotectin and Ischemia Modified Albumin Serum to Measure Disease Activity in Behçet's Disease
NCT05868538
Vascular Affection in Behcet Disease
NCT06280430
Serum Regucalcin Level and Chronic Hepatitis B
NCT05435599
Serum Elafin and Vascular Affection in Behcet Disease
NCT06272929
Pan-immune-inflammation Value (PIN) in Behçet's Disease and Its Correlation With Disease Activity
NCT06729112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
• Group (I): Forty two patients diagnosed to have Behcets disease fulfilling the International Criteria for BD .
Group (II): including 42 age and sex matching healthy volunteers as control group.
(A) Clinical evaluation
1. Complete history taking.
2. Thorough clinical examination including opthalmologic evaluation .
3. Disease activity using The Behcet's disease current activity form (BD-DAF) . (B) Laboratory assessment:
All patients will be subjected to the following measurements:
1. ESR
2. CRP
3. CBC
4. liver and kidney function tests
d) Serum Endocan level e)triglycrides f) cholestrol C) carotid intima media thickness
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behçet group
Forty two patients diagnosed to have Behçet disease fulfilling the International Study Group Criteria for Behçet disease in whom measurement of serum endocan levels will be performed.
measurement of serum endocan
measurement of serum levels of endocan
control group
including 42 age and sex matching healthy volunteers as control group in whom measurement of serum endocan levels will be performed.
measurement of serum endocan
measurement of serum levels of endocan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
measurement of serum endocan
measurement of serum levels of endocan
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* malignancy
* other connective tissue disease
* chronic liver disease
* chronic kidney disease
* Diabetes mellitus
* hypertension
* hyperlipidemia
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Benha University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Waleed Ahmed Salaheldeen Hassan
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Waleed Hassan, MD
Role: PRINCIPAL_INVESTIGATOR
Benha university- Qaluibya- Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benha University Hospital
Banhā, Qalyubia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BenhaU22019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.